Global Haemophilus Parasuis Bivalent Vaccine Supply, Demand and Key Producers, 2023-2029
The global Haemophilus Parasuis Bivalent Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Haemophilus parasuis disease, also known as Grazer's disease, is an upper respiratory infectious disease of pigs caused by Haemophilus parasuis (HPS), mainly infecting piglets before and after weaning, clinically manifested as multiple fibrosis Serositis, arthritis and meningitis. The inactivated vaccine against Haemophilus parasuis can effectively prevent Haemophilus parasuis and reduce the mortality rate of Haemophilus parasuis infection.
This report studies the global Haemophilus Parasuis Bivalent Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Haemophilus Parasuis Bivalent Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Haemophilus Parasuis Bivalent Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Haemophilus Parasuis Bivalent Vaccine total production and demand, 2018-2029, (K Doses)
Global Haemophilus Parasuis Bivalent Vaccine total production value, 2018-2029, (USD Million)
Global Haemophilus Parasuis Bivalent Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Haemophilus Parasuis Bivalent Vaccine consumption by region & country, CAGR, 2018-2029 & (K Doses)
U.S. VS China: Haemophilus Parasuis Bivalent Vaccine domestic production, consumption, key domestic manufacturers and share
Global Haemophilus Parasuis Bivalent Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Doses)
Global Haemophilus Parasuis Bivalent Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Haemophilus Parasuis Bivalent Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
This reports profiles key players in the global Haemophilus Parasuis Bivalent Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer-Ingelheim, Eurovet, Hipra, Nisseiken, Merck Animal Health, SPAH, Pulike Biological Engineering and China Animal Husbandry Industry, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Haemophilus Parasuis Bivalent Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Haemophilus Parasuis Bivalent Vaccine Market, By Region:
1. How big is the global Haemophilus Parasuis Bivalent Vaccine market?
2. What is the demand of the global Haemophilus Parasuis Bivalent Vaccine market?
3. What is the year over year growth of the global Haemophilus Parasuis Bivalent Vaccine market?
4. What is the production and production value of the global Haemophilus Parasuis Bivalent Vaccine market?
5. Who are the key producers in the global Haemophilus Parasuis Bivalent Vaccine market?
6. What are the growth factors driving the market demand?
Haemophilus parasuis disease, also known as Grazer's disease, is an upper respiratory infectious disease of pigs caused by Haemophilus parasuis (HPS), mainly infecting piglets before and after weaning, clinically manifested as multiple fibrosis Serositis, arthritis and meningitis. The inactivated vaccine against Haemophilus parasuis can effectively prevent Haemophilus parasuis and reduce the mortality rate of Haemophilus parasuis infection.
This report studies the global Haemophilus Parasuis Bivalent Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Haemophilus Parasuis Bivalent Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Haemophilus Parasuis Bivalent Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Haemophilus Parasuis Bivalent Vaccine total production and demand, 2018-2029, (K Doses)
Global Haemophilus Parasuis Bivalent Vaccine total production value, 2018-2029, (USD Million)
Global Haemophilus Parasuis Bivalent Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Haemophilus Parasuis Bivalent Vaccine consumption by region & country, CAGR, 2018-2029 & (K Doses)
U.S. VS China: Haemophilus Parasuis Bivalent Vaccine domestic production, consumption, key domestic manufacturers and share
Global Haemophilus Parasuis Bivalent Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Doses)
Global Haemophilus Parasuis Bivalent Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Haemophilus Parasuis Bivalent Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
This reports profiles key players in the global Haemophilus Parasuis Bivalent Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer-Ingelheim, Eurovet, Hipra, Nisseiken, Merck Animal Health, SPAH, Pulike Biological Engineering and China Animal Husbandry Industry, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Haemophilus Parasuis Bivalent Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Haemophilus Parasuis Bivalent Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Bivalent Inactivated Vaccine
- Trivalent Inactivated Vaccine
- Quadrivalent Inactivated Vaccine
- Piglets
- Adults Pigs
- Zoetis
- Boehringer-Ingelheim
- Eurovet
- Hipra
- Nisseiken
- Merck Animal Health
- SPAH
- Pulike Biological Engineering
- China Animal Husbandry Industry
- Wuhan Keqian Biology
- Wo Hua Biotech
- Zhejiang Ceva Ebvac Biotech
- Luoyang Huizhong Biotech
- Beijing Centrebio Biology
- Shandong Huahong Bioengineering
- Ringpu
1. How big is the global Haemophilus Parasuis Bivalent Vaccine market?
2. What is the demand of the global Haemophilus Parasuis Bivalent Vaccine market?
3. What is the year over year growth of the global Haemophilus Parasuis Bivalent Vaccine market?
4. What is the production and production value of the global Haemophilus Parasuis Bivalent Vaccine market?
5. Who are the key producers in the global Haemophilus Parasuis Bivalent Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Haemophilus Parasuis Bivalent Vaccine Introduction
1.2 World Haemophilus Parasuis Bivalent Vaccine Supply & Forecast
1.2.1 World Haemophilus Parasuis Bivalent Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Haemophilus Parasuis Bivalent Vaccine Production (2018-2029)
1.2.3 World Haemophilus Parasuis Bivalent Vaccine Pricing Trends (2018-2029)
1.3 World Haemophilus Parasuis Bivalent Vaccine Production by Region (Based on Production Site)
1.3.1 World Haemophilus Parasuis Bivalent Vaccine Production Value by Region (2018-2029)
1.3.2 World Haemophilus Parasuis Bivalent Vaccine Production by Region (2018-2029)
1.3.3 World Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2018-2029)
1.3.4 North America Haemophilus Parasuis Bivalent Vaccine Production (2018-2029)
1.3.5 Europe Haemophilus Parasuis Bivalent Vaccine Production (2018-2029)
1.3.6 China Haemophilus Parasuis Bivalent Vaccine Production (2018-2029)
1.3.7 Japan Haemophilus Parasuis Bivalent Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Haemophilus Parasuis Bivalent Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Haemophilus Parasuis Bivalent Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Haemophilus Parasuis Bivalent Vaccine Demand (2018-2029)
2.2 World Haemophilus Parasuis Bivalent Vaccine Consumption by Region
2.2.1 World Haemophilus Parasuis Bivalent Vaccine Consumption by Region (2018-2023)
2.2.2 World Haemophilus Parasuis Bivalent Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
2.4 China Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
2.5 Europe Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
2.6 Japan Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
2.7 South Korea Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
2.8 ASEAN Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
2.9 India Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
3 WORLD HAEMOPHILUS PARASUIS BIVALENT VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Haemophilus Parasuis Bivalent Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Haemophilus Parasuis Bivalent Vaccine Production by Manufacturer (2018-2023)
3.3 World Haemophilus Parasuis Bivalent Vaccine Average Price by Manufacturer (2018-2023)
3.4 Haemophilus Parasuis Bivalent Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Haemophilus Parasuis Bivalent Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Haemophilus Parasuis Bivalent Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Haemophilus Parasuis Bivalent Vaccine in 2022
3.6 Haemophilus Parasuis Bivalent Vaccine Market: Overall Company Footprint Analysis
3.6.1 Haemophilus Parasuis Bivalent Vaccine Market: Region Footprint
3.6.2 Haemophilus Parasuis Bivalent Vaccine Market: Company Product Type Footprint
3.6.3 Haemophilus Parasuis Bivalent Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Value Comparison
4.1.1 United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Comparison
4.2.1 United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Haemophilus Parasuis Bivalent Vaccine Consumption Comparison
4.3.1 United States VS China: Haemophilus Parasuis Bivalent Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Haemophilus Parasuis Bivalent Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Haemophilus Parasuis Bivalent Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Haemophilus Parasuis Bivalent Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production (2018-2023)
4.5 China Based Haemophilus Parasuis Bivalent Vaccine Manufacturers and Market Share
4.5.1 China Based Haemophilus Parasuis Bivalent Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production (2018-2023)
4.6 Rest of World Based Haemophilus Parasuis Bivalent Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Haemophilus Parasuis Bivalent Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Haemophilus Parasuis Bivalent Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Bivalent Inactivated Vaccine
5.2.2 Trivalent Inactivated Vaccine
5.2.3 Quadrivalent Inactivated Vaccine
5.3 Market Segment by Type
5.3.1 World Haemophilus Parasuis Bivalent Vaccine Production by Type (2018-2029)
5.3.2 World Haemophilus Parasuis Bivalent Vaccine Production Value by Type (2018-2029)
5.3.3 World Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Haemophilus Parasuis Bivalent Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Piglets
6.2.2 Adults Pigs
6.3 Market Segment by Application
6.3.1 World Haemophilus Parasuis Bivalent Vaccine Production by Application (2018-2029)
6.3.2 World Haemophilus Parasuis Bivalent Vaccine Production Value by Application (2018-2029)
6.3.3 World Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Zoetis
7.1.1 Zoetis Details
7.1.2 Zoetis Major Business
7.1.3 Zoetis Haemophilus Parasuis Bivalent Vaccine Product and Services
7.1.4 Zoetis Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Zoetis Recent Developments/Updates
7.1.6 Zoetis Competitive Strengths & Weaknesses
7.2 Boehringer-Ingelheim
7.2.1 Boehringer-Ingelheim Details
7.2.2 Boehringer-Ingelheim Major Business
7.2.3 Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Product and Services
7.2.4 Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Boehringer-Ingelheim Recent Developments/Updates
7.2.6 Boehringer-Ingelheim Competitive Strengths & Weaknesses
7.3 Eurovet
7.3.1 Eurovet Details
7.3.2 Eurovet Major Business
7.3.3 Eurovet Haemophilus Parasuis Bivalent Vaccine Product and Services
7.3.4 Eurovet Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Eurovet Recent Developments/Updates
7.3.6 Eurovet Competitive Strengths & Weaknesses
7.4 Hipra
7.4.1 Hipra Details
7.4.2 Hipra Major Business
7.4.3 Hipra Haemophilus Parasuis Bivalent Vaccine Product and Services
7.4.4 Hipra Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Hipra Recent Developments/Updates
7.4.6 Hipra Competitive Strengths & Weaknesses
7.5 Nisseiken
7.5.1 Nisseiken Details
7.5.2 Nisseiken Major Business
7.5.3 Nisseiken Haemophilus Parasuis Bivalent Vaccine Product and Services
7.5.4 Nisseiken Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Nisseiken Recent Developments/Updates
7.5.6 Nisseiken Competitive Strengths & Weaknesses
7.6 Merck Animal Health
7.6.1 Merck Animal Health Details
7.6.2 Merck Animal Health Major Business
7.6.3 Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Product and Services
7.6.4 Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Merck Animal Health Recent Developments/Updates
7.6.6 Merck Animal Health Competitive Strengths & Weaknesses
7.7 SPAH
7.7.1 SPAH Details
7.7.2 SPAH Major Business
7.7.3 SPAH Haemophilus Parasuis Bivalent Vaccine Product and Services
7.7.4 SPAH Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 SPAH Recent Developments/Updates
7.7.6 SPAH Competitive Strengths & Weaknesses
7.8 Pulike Biological Engineering
7.8.1 Pulike Biological Engineering Details
7.8.2 Pulike Biological Engineering Major Business
7.8.3 Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Product and Services
7.8.4 Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pulike Biological Engineering Recent Developments/Updates
7.8.6 Pulike Biological Engineering Competitive Strengths & Weaknesses
7.9 China Animal Husbandry Industry
7.9.1 China Animal Husbandry Industry Details
7.9.2 China Animal Husbandry Industry Major Business
7.9.3 China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Product and Services
7.9.4 China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 China Animal Husbandry Industry Recent Developments/Updates
7.9.6 China Animal Husbandry Industry Competitive Strengths & Weaknesses
7.10 Wuhan Keqian Biology
7.10.1 Wuhan Keqian Biology Details
7.10.2 Wuhan Keqian Biology Major Business
7.10.3 Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
7.10.4 Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Wuhan Keqian Biology Recent Developments/Updates
7.10.6 Wuhan Keqian Biology Competitive Strengths & Weaknesses
7.11 Wo Hua Biotech
7.11.1 Wo Hua Biotech Details
7.11.2 Wo Hua Biotech Major Business
7.11.3 Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
7.11.4 Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Wo Hua Biotech Recent Developments/Updates
7.11.6 Wo Hua Biotech Competitive Strengths & Weaknesses
7.12 Zhejiang Ceva Ebvac Biotech
7.12.1 Zhejiang Ceva Ebvac Biotech Details
7.12.2 Zhejiang Ceva Ebvac Biotech Major Business
7.12.3 Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
7.12.4 Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Zhejiang Ceva Ebvac Biotech Recent Developments/Updates
7.12.6 Zhejiang Ceva Ebvac Biotech Competitive Strengths & Weaknesses
7.13 Luoyang Huizhong Biotech
7.13.1 Luoyang Huizhong Biotech Details
7.13.2 Luoyang Huizhong Biotech Major Business
7.13.3 Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
7.13.4 Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Luoyang Huizhong Biotech Recent Developments/Updates
7.13.6 Luoyang Huizhong Biotech Competitive Strengths & Weaknesses
7.14 Beijing Centrebio Biology
7.14.1 Beijing Centrebio Biology Details
7.14.2 Beijing Centrebio Biology Major Business
7.14.3 Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
7.14.4 Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Beijing Centrebio Biology Recent Developments/Updates
7.14.6 Beijing Centrebio Biology Competitive Strengths & Weaknesses
7.15 Shandong Huahong Bioengineering
7.15.1 Shandong Huahong Bioengineering Details
7.15.2 Shandong Huahong Bioengineering Major Business
7.15.3 Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Product and Services
7.15.4 Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Shandong Huahong Bioengineering Recent Developments/Updates
7.15.6 Shandong Huahong Bioengineering Competitive Strengths & Weaknesses
7.16 Ringpu
7.16.1 Ringpu Details
7.16.2 Ringpu Major Business
7.16.3 Ringpu Haemophilus Parasuis Bivalent Vaccine Product and Services
7.16.4 Ringpu Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Ringpu Recent Developments/Updates
7.16.6 Ringpu Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Haemophilus Parasuis Bivalent Vaccine Industry Chain
8.2 Haemophilus Parasuis Bivalent Vaccine Upstream Analysis
8.2.1 Haemophilus Parasuis Bivalent Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Haemophilus Parasuis Bivalent Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Haemophilus Parasuis Bivalent Vaccine Production Mode
8.6 Haemophilus Parasuis Bivalent Vaccine Procurement Model
8.7 Haemophilus Parasuis Bivalent Vaccine Industry Sales Model and Sales Channels
8.7.1 Haemophilus Parasuis Bivalent Vaccine Sales Model
8.7.2 Haemophilus Parasuis Bivalent Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Haemophilus Parasuis Bivalent Vaccine Introduction
1.2 World Haemophilus Parasuis Bivalent Vaccine Supply & Forecast
1.2.1 World Haemophilus Parasuis Bivalent Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Haemophilus Parasuis Bivalent Vaccine Production (2018-2029)
1.2.3 World Haemophilus Parasuis Bivalent Vaccine Pricing Trends (2018-2029)
1.3 World Haemophilus Parasuis Bivalent Vaccine Production by Region (Based on Production Site)
1.3.1 World Haemophilus Parasuis Bivalent Vaccine Production Value by Region (2018-2029)
1.3.2 World Haemophilus Parasuis Bivalent Vaccine Production by Region (2018-2029)
1.3.3 World Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2018-2029)
1.3.4 North America Haemophilus Parasuis Bivalent Vaccine Production (2018-2029)
1.3.5 Europe Haemophilus Parasuis Bivalent Vaccine Production (2018-2029)
1.3.6 China Haemophilus Parasuis Bivalent Vaccine Production (2018-2029)
1.3.7 Japan Haemophilus Parasuis Bivalent Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Haemophilus Parasuis Bivalent Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Haemophilus Parasuis Bivalent Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Haemophilus Parasuis Bivalent Vaccine Demand (2018-2029)
2.2 World Haemophilus Parasuis Bivalent Vaccine Consumption by Region
2.2.1 World Haemophilus Parasuis Bivalent Vaccine Consumption by Region (2018-2023)
2.2.2 World Haemophilus Parasuis Bivalent Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
2.4 China Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
2.5 Europe Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
2.6 Japan Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
2.7 South Korea Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
2.8 ASEAN Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
2.9 India Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029)
3 WORLD HAEMOPHILUS PARASUIS BIVALENT VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Haemophilus Parasuis Bivalent Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Haemophilus Parasuis Bivalent Vaccine Production by Manufacturer (2018-2023)
3.3 World Haemophilus Parasuis Bivalent Vaccine Average Price by Manufacturer (2018-2023)
3.4 Haemophilus Parasuis Bivalent Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Haemophilus Parasuis Bivalent Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Haemophilus Parasuis Bivalent Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Haemophilus Parasuis Bivalent Vaccine in 2022
3.6 Haemophilus Parasuis Bivalent Vaccine Market: Overall Company Footprint Analysis
3.6.1 Haemophilus Parasuis Bivalent Vaccine Market: Region Footprint
3.6.2 Haemophilus Parasuis Bivalent Vaccine Market: Company Product Type Footprint
3.6.3 Haemophilus Parasuis Bivalent Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Value Comparison
4.1.1 United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Comparison
4.2.1 United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Haemophilus Parasuis Bivalent Vaccine Consumption Comparison
4.3.1 United States VS China: Haemophilus Parasuis Bivalent Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Haemophilus Parasuis Bivalent Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Haemophilus Parasuis Bivalent Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Haemophilus Parasuis Bivalent Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production (2018-2023)
4.5 China Based Haemophilus Parasuis Bivalent Vaccine Manufacturers and Market Share
4.5.1 China Based Haemophilus Parasuis Bivalent Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production (2018-2023)
4.6 Rest of World Based Haemophilus Parasuis Bivalent Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Haemophilus Parasuis Bivalent Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Haemophilus Parasuis Bivalent Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Bivalent Inactivated Vaccine
5.2.2 Trivalent Inactivated Vaccine
5.2.3 Quadrivalent Inactivated Vaccine
5.3 Market Segment by Type
5.3.1 World Haemophilus Parasuis Bivalent Vaccine Production by Type (2018-2029)
5.3.2 World Haemophilus Parasuis Bivalent Vaccine Production Value by Type (2018-2029)
5.3.3 World Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Haemophilus Parasuis Bivalent Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Piglets
6.2.2 Adults Pigs
6.3 Market Segment by Application
6.3.1 World Haemophilus Parasuis Bivalent Vaccine Production by Application (2018-2029)
6.3.2 World Haemophilus Parasuis Bivalent Vaccine Production Value by Application (2018-2029)
6.3.3 World Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Zoetis
7.1.1 Zoetis Details
7.1.2 Zoetis Major Business
7.1.3 Zoetis Haemophilus Parasuis Bivalent Vaccine Product and Services
7.1.4 Zoetis Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Zoetis Recent Developments/Updates
7.1.6 Zoetis Competitive Strengths & Weaknesses
7.2 Boehringer-Ingelheim
7.2.1 Boehringer-Ingelheim Details
7.2.2 Boehringer-Ingelheim Major Business
7.2.3 Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Product and Services
7.2.4 Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Boehringer-Ingelheim Recent Developments/Updates
7.2.6 Boehringer-Ingelheim Competitive Strengths & Weaknesses
7.3 Eurovet
7.3.1 Eurovet Details
7.3.2 Eurovet Major Business
7.3.3 Eurovet Haemophilus Parasuis Bivalent Vaccine Product and Services
7.3.4 Eurovet Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Eurovet Recent Developments/Updates
7.3.6 Eurovet Competitive Strengths & Weaknesses
7.4 Hipra
7.4.1 Hipra Details
7.4.2 Hipra Major Business
7.4.3 Hipra Haemophilus Parasuis Bivalent Vaccine Product and Services
7.4.4 Hipra Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Hipra Recent Developments/Updates
7.4.6 Hipra Competitive Strengths & Weaknesses
7.5 Nisseiken
7.5.1 Nisseiken Details
7.5.2 Nisseiken Major Business
7.5.3 Nisseiken Haemophilus Parasuis Bivalent Vaccine Product and Services
7.5.4 Nisseiken Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Nisseiken Recent Developments/Updates
7.5.6 Nisseiken Competitive Strengths & Weaknesses
7.6 Merck Animal Health
7.6.1 Merck Animal Health Details
7.6.2 Merck Animal Health Major Business
7.6.3 Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Product and Services
7.6.4 Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Merck Animal Health Recent Developments/Updates
7.6.6 Merck Animal Health Competitive Strengths & Weaknesses
7.7 SPAH
7.7.1 SPAH Details
7.7.2 SPAH Major Business
7.7.3 SPAH Haemophilus Parasuis Bivalent Vaccine Product and Services
7.7.4 SPAH Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 SPAH Recent Developments/Updates
7.7.6 SPAH Competitive Strengths & Weaknesses
7.8 Pulike Biological Engineering
7.8.1 Pulike Biological Engineering Details
7.8.2 Pulike Biological Engineering Major Business
7.8.3 Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Product and Services
7.8.4 Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pulike Biological Engineering Recent Developments/Updates
7.8.6 Pulike Biological Engineering Competitive Strengths & Weaknesses
7.9 China Animal Husbandry Industry
7.9.1 China Animal Husbandry Industry Details
7.9.2 China Animal Husbandry Industry Major Business
7.9.3 China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Product and Services
7.9.4 China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 China Animal Husbandry Industry Recent Developments/Updates
7.9.6 China Animal Husbandry Industry Competitive Strengths & Weaknesses
7.10 Wuhan Keqian Biology
7.10.1 Wuhan Keqian Biology Details
7.10.2 Wuhan Keqian Biology Major Business
7.10.3 Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
7.10.4 Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Wuhan Keqian Biology Recent Developments/Updates
7.10.6 Wuhan Keqian Biology Competitive Strengths & Weaknesses
7.11 Wo Hua Biotech
7.11.1 Wo Hua Biotech Details
7.11.2 Wo Hua Biotech Major Business
7.11.3 Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
7.11.4 Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Wo Hua Biotech Recent Developments/Updates
7.11.6 Wo Hua Biotech Competitive Strengths & Weaknesses
7.12 Zhejiang Ceva Ebvac Biotech
7.12.1 Zhejiang Ceva Ebvac Biotech Details
7.12.2 Zhejiang Ceva Ebvac Biotech Major Business
7.12.3 Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
7.12.4 Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Zhejiang Ceva Ebvac Biotech Recent Developments/Updates
7.12.6 Zhejiang Ceva Ebvac Biotech Competitive Strengths & Weaknesses
7.13 Luoyang Huizhong Biotech
7.13.1 Luoyang Huizhong Biotech Details
7.13.2 Luoyang Huizhong Biotech Major Business
7.13.3 Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
7.13.4 Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Luoyang Huizhong Biotech Recent Developments/Updates
7.13.6 Luoyang Huizhong Biotech Competitive Strengths & Weaknesses
7.14 Beijing Centrebio Biology
7.14.1 Beijing Centrebio Biology Details
7.14.2 Beijing Centrebio Biology Major Business
7.14.3 Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
7.14.4 Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Beijing Centrebio Biology Recent Developments/Updates
7.14.6 Beijing Centrebio Biology Competitive Strengths & Weaknesses
7.15 Shandong Huahong Bioengineering
7.15.1 Shandong Huahong Bioengineering Details
7.15.2 Shandong Huahong Bioengineering Major Business
7.15.3 Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Product and Services
7.15.4 Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Shandong Huahong Bioengineering Recent Developments/Updates
7.15.6 Shandong Huahong Bioengineering Competitive Strengths & Weaknesses
7.16 Ringpu
7.16.1 Ringpu Details
7.16.2 Ringpu Major Business
7.16.3 Ringpu Haemophilus Parasuis Bivalent Vaccine Product and Services
7.16.4 Ringpu Haemophilus Parasuis Bivalent Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Ringpu Recent Developments/Updates
7.16.6 Ringpu Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Haemophilus Parasuis Bivalent Vaccine Industry Chain
8.2 Haemophilus Parasuis Bivalent Vaccine Upstream Analysis
8.2.1 Haemophilus Parasuis Bivalent Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Haemophilus Parasuis Bivalent Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Haemophilus Parasuis Bivalent Vaccine Production Mode
8.6 Haemophilus Parasuis Bivalent Vaccine Procurement Model
8.7 Haemophilus Parasuis Bivalent Vaccine Industry Sales Model and Sales Channels
8.7.1 Haemophilus Parasuis Bivalent Vaccine Sales Model
8.7.2 Haemophilus Parasuis Bivalent Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Haemophilus Parasuis Bivalent Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Haemophilus Parasuis Bivalent Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Haemophilus Parasuis Bivalent Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Haemophilus Parasuis Bivalent Vaccine Production by Region (2018-2023) & (K Doses)
Table 7. World Haemophilus Parasuis Bivalent Vaccine Production by Region (2024-2029) & (K Doses)
Table 8. World Haemophilus Parasuis Bivalent Vaccine Production Market Share by Region (2018-2023)
Table 9. World Haemophilus Parasuis Bivalent Vaccine Production Market Share by Region (2024-2029)
Table 10. World Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 11. World Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 12. Haemophilus Parasuis Bivalent Vaccine Major Market Trends
Table 13. World Haemophilus Parasuis Bivalent Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Doses)
Table 14. World Haemophilus Parasuis Bivalent Vaccine Consumption by Region (2018-2023) & (K Doses)
Table 15. World Haemophilus Parasuis Bivalent Vaccine Consumption Forecast by Region (2024-2029) & (K Doses)
Table 16. World Haemophilus Parasuis Bivalent Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Haemophilus Parasuis Bivalent Vaccine Producers in 2022
Table 18. World Haemophilus Parasuis Bivalent Vaccine Production by Manufacturer (2018-2023) & (K Doses)
Table 19. Production Market Share of Key Haemophilus Parasuis Bivalent Vaccine Producers in 2022
Table 20. World Haemophilus Parasuis Bivalent Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 21. Global Haemophilus Parasuis Bivalent Vaccine Company Evaluation Quadrant
Table 22. World Haemophilus Parasuis Bivalent Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Haemophilus Parasuis Bivalent Vaccine Production Site of Key Manufacturer
Table 24. Haemophilus Parasuis Bivalent Vaccine Market: Company Product Type Footprint
Table 25. Haemophilus Parasuis Bivalent Vaccine Market: Company Product Application Footprint
Table 26. Haemophilus Parasuis Bivalent Vaccine Competitive Factors
Table 27. Haemophilus Parasuis Bivalent Vaccine New Entrant and Capacity Expansion Plans
Table 28. Haemophilus Parasuis Bivalent Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Haemophilus Parasuis Bivalent Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Haemophilus Parasuis Bivalent Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Doses)
Table 31. United States VS China Haemophilus Parasuis Bivalent Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Doses)
Table 32. United States Based Haemophilus Parasuis Bivalent Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production (2018-2023) & (K Doses)
Table 36. United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Market Share (2018-2023)
Table 37. China Based Haemophilus Parasuis Bivalent Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production (2018-2023) & (K Doses)
Table 41. China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Haemophilus Parasuis Bivalent Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production (2018-2023) & (K Doses)
Table 46. Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Market Share (2018-2023)
Table 47. World Haemophilus Parasuis Bivalent Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Haemophilus Parasuis Bivalent Vaccine Production by Type (2018-2023) & (K Doses)
Table 49. World Haemophilus Parasuis Bivalent Vaccine Production by Type (2024-2029) & (K Doses)
Table 50. World Haemophilus Parasuis Bivalent Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Haemophilus Parasuis Bivalent Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 53. World Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 54. World Haemophilus Parasuis Bivalent Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Haemophilus Parasuis Bivalent Vaccine Production by Application (2018-2023) & (K Doses)
Table 56. World Haemophilus Parasuis Bivalent Vaccine Production by Application (2024-2029) & (K Doses)
Table 57. World Haemophilus Parasuis Bivalent Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Haemophilus Parasuis Bivalent Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 60. World Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 61. Zoetis Basic Information, Manufacturing Base and Competitors
Table 62. Zoetis Major Business
Table 63. Zoetis Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 64. Zoetis Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Zoetis Recent Developments/Updates
Table 66. Zoetis Competitive Strengths & Weaknesses
Table 67. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 68. Boehringer-Ingelheim Major Business
Table 69. Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 70. Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Boehringer-Ingelheim Recent Developments/Updates
Table 72. Boehringer-Ingelheim Competitive Strengths & Weaknesses
Table 73. Eurovet Basic Information, Manufacturing Base and Competitors
Table 74. Eurovet Major Business
Table 75. Eurovet Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 76. Eurovet Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Eurovet Recent Developments/Updates
Table 78. Eurovet Competitive Strengths & Weaknesses
Table 79. Hipra Basic Information, Manufacturing Base and Competitors
Table 80. Hipra Major Business
Table 81. Hipra Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 82. Hipra Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Hipra Recent Developments/Updates
Table 84. Hipra Competitive Strengths & Weaknesses
Table 85. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 86. Nisseiken Major Business
Table 87. Nisseiken Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 88. Nisseiken Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Nisseiken Recent Developments/Updates
Table 90. Nisseiken Competitive Strengths & Weaknesses
Table 91. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 92. Merck Animal Health Major Business
Table 93. Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 94. Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Merck Animal Health Recent Developments/Updates
Table 96. Merck Animal Health Competitive Strengths & Weaknesses
Table 97. SPAH Basic Information, Manufacturing Base and Competitors
Table 98. SPAH Major Business
Table 99. SPAH Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 100. SPAH Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. SPAH Recent Developments/Updates
Table 102. SPAH Competitive Strengths & Weaknesses
Table 103. Pulike Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 104. Pulike Biological Engineering Major Business
Table 105. Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 106. Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pulike Biological Engineering Recent Developments/Updates
Table 108. Pulike Biological Engineering Competitive Strengths & Weaknesses
Table 109. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 110. China Animal Husbandry Industry Major Business
Table 111. China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 112. China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. China Animal Husbandry Industry Recent Developments/Updates
Table 114. China Animal Husbandry Industry Competitive Strengths & Weaknesses
Table 115. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 116. Wuhan Keqian Biology Major Business
Table 117. Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 118. Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Wuhan Keqian Biology Recent Developments/Updates
Table 120. Wuhan Keqian Biology Competitive Strengths & Weaknesses
Table 121. Wo Hua Biotech Basic Information, Manufacturing Base and Competitors
Table 122. Wo Hua Biotech Major Business
Table 123. Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 124. Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Wo Hua Biotech Recent Developments/Updates
Table 126. Wo Hua Biotech Competitive Strengths & Weaknesses
Table 127. Zhejiang Ceva Ebvac Biotech Basic Information, Manufacturing Base and Competitors
Table 128. Zhejiang Ceva Ebvac Biotech Major Business
Table 129. Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 130. Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Zhejiang Ceva Ebvac Biotech Recent Developments/Updates
Table 132. Zhejiang Ceva Ebvac Biotech Competitive Strengths & Weaknesses
Table 133. Luoyang Huizhong Biotech Basic Information, Manufacturing Base and Competitors
Table 134. Luoyang Huizhong Biotech Major Business
Table 135. Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 136. Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Luoyang Huizhong Biotech Recent Developments/Updates
Table 138. Luoyang Huizhong Biotech Competitive Strengths & Weaknesses
Table 139. Beijing Centrebio Biology Basic Information, Manufacturing Base and Competitors
Table 140. Beijing Centrebio Biology Major Business
Table 141. Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 142. Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Beijing Centrebio Biology Recent Developments/Updates
Table 144. Beijing Centrebio Biology Competitive Strengths & Weaknesses
Table 145. Shandong Huahong Bioengineering Basic Information, Manufacturing Base and Competitors
Table 146. Shandong Huahong Bioengineering Major Business
Table 147. Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 148. Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Shandong Huahong Bioengineering Recent Developments/Updates
Table 150. Ringpu Basic Information, Manufacturing Base and Competitors
Table 151. Ringpu Major Business
Table 152. Ringpu Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 153. Ringpu Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Haemophilus Parasuis Bivalent Vaccine Upstream (Raw Materials)
Table 155. Haemophilus Parasuis Bivalent Vaccine Typical Customers
Table 156. Haemophilus Parasuis Bivalent Vaccine Typical Distributors
Table 1. World Haemophilus Parasuis Bivalent Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Haemophilus Parasuis Bivalent Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Haemophilus Parasuis Bivalent Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Haemophilus Parasuis Bivalent Vaccine Production by Region (2018-2023) & (K Doses)
Table 7. World Haemophilus Parasuis Bivalent Vaccine Production by Region (2024-2029) & (K Doses)
Table 8. World Haemophilus Parasuis Bivalent Vaccine Production Market Share by Region (2018-2023)
Table 9. World Haemophilus Parasuis Bivalent Vaccine Production Market Share by Region (2024-2029)
Table 10. World Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 11. World Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 12. Haemophilus Parasuis Bivalent Vaccine Major Market Trends
Table 13. World Haemophilus Parasuis Bivalent Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Doses)
Table 14. World Haemophilus Parasuis Bivalent Vaccine Consumption by Region (2018-2023) & (K Doses)
Table 15. World Haemophilus Parasuis Bivalent Vaccine Consumption Forecast by Region (2024-2029) & (K Doses)
Table 16. World Haemophilus Parasuis Bivalent Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Haemophilus Parasuis Bivalent Vaccine Producers in 2022
Table 18. World Haemophilus Parasuis Bivalent Vaccine Production by Manufacturer (2018-2023) & (K Doses)
Table 19. Production Market Share of Key Haemophilus Parasuis Bivalent Vaccine Producers in 2022
Table 20. World Haemophilus Parasuis Bivalent Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 21. Global Haemophilus Parasuis Bivalent Vaccine Company Evaluation Quadrant
Table 22. World Haemophilus Parasuis Bivalent Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Haemophilus Parasuis Bivalent Vaccine Production Site of Key Manufacturer
Table 24. Haemophilus Parasuis Bivalent Vaccine Market: Company Product Type Footprint
Table 25. Haemophilus Parasuis Bivalent Vaccine Market: Company Product Application Footprint
Table 26. Haemophilus Parasuis Bivalent Vaccine Competitive Factors
Table 27. Haemophilus Parasuis Bivalent Vaccine New Entrant and Capacity Expansion Plans
Table 28. Haemophilus Parasuis Bivalent Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Haemophilus Parasuis Bivalent Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Haemophilus Parasuis Bivalent Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Doses)
Table 31. United States VS China Haemophilus Parasuis Bivalent Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Doses)
Table 32. United States Based Haemophilus Parasuis Bivalent Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production (2018-2023) & (K Doses)
Table 36. United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Market Share (2018-2023)
Table 37. China Based Haemophilus Parasuis Bivalent Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production (2018-2023) & (K Doses)
Table 41. China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Haemophilus Parasuis Bivalent Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production (2018-2023) & (K Doses)
Table 46. Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Market Share (2018-2023)
Table 47. World Haemophilus Parasuis Bivalent Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Haemophilus Parasuis Bivalent Vaccine Production by Type (2018-2023) & (K Doses)
Table 49. World Haemophilus Parasuis Bivalent Vaccine Production by Type (2024-2029) & (K Doses)
Table 50. World Haemophilus Parasuis Bivalent Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Haemophilus Parasuis Bivalent Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 53. World Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 54. World Haemophilus Parasuis Bivalent Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Haemophilus Parasuis Bivalent Vaccine Production by Application (2018-2023) & (K Doses)
Table 56. World Haemophilus Parasuis Bivalent Vaccine Production by Application (2024-2029) & (K Doses)
Table 57. World Haemophilus Parasuis Bivalent Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Haemophilus Parasuis Bivalent Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 60. World Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 61. Zoetis Basic Information, Manufacturing Base and Competitors
Table 62. Zoetis Major Business
Table 63. Zoetis Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 64. Zoetis Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Zoetis Recent Developments/Updates
Table 66. Zoetis Competitive Strengths & Weaknesses
Table 67. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 68. Boehringer-Ingelheim Major Business
Table 69. Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 70. Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Boehringer-Ingelheim Recent Developments/Updates
Table 72. Boehringer-Ingelheim Competitive Strengths & Weaknesses
Table 73. Eurovet Basic Information, Manufacturing Base and Competitors
Table 74. Eurovet Major Business
Table 75. Eurovet Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 76. Eurovet Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Eurovet Recent Developments/Updates
Table 78. Eurovet Competitive Strengths & Weaknesses
Table 79. Hipra Basic Information, Manufacturing Base and Competitors
Table 80. Hipra Major Business
Table 81. Hipra Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 82. Hipra Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Hipra Recent Developments/Updates
Table 84. Hipra Competitive Strengths & Weaknesses
Table 85. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 86. Nisseiken Major Business
Table 87. Nisseiken Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 88. Nisseiken Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Nisseiken Recent Developments/Updates
Table 90. Nisseiken Competitive Strengths & Weaknesses
Table 91. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 92. Merck Animal Health Major Business
Table 93. Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 94. Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Merck Animal Health Recent Developments/Updates
Table 96. Merck Animal Health Competitive Strengths & Weaknesses
Table 97. SPAH Basic Information, Manufacturing Base and Competitors
Table 98. SPAH Major Business
Table 99. SPAH Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 100. SPAH Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. SPAH Recent Developments/Updates
Table 102. SPAH Competitive Strengths & Weaknesses
Table 103. Pulike Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 104. Pulike Biological Engineering Major Business
Table 105. Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 106. Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pulike Biological Engineering Recent Developments/Updates
Table 108. Pulike Biological Engineering Competitive Strengths & Weaknesses
Table 109. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 110. China Animal Husbandry Industry Major Business
Table 111. China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 112. China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. China Animal Husbandry Industry Recent Developments/Updates
Table 114. China Animal Husbandry Industry Competitive Strengths & Weaknesses
Table 115. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 116. Wuhan Keqian Biology Major Business
Table 117. Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 118. Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Wuhan Keqian Biology Recent Developments/Updates
Table 120. Wuhan Keqian Biology Competitive Strengths & Weaknesses
Table 121. Wo Hua Biotech Basic Information, Manufacturing Base and Competitors
Table 122. Wo Hua Biotech Major Business
Table 123. Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 124. Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Wo Hua Biotech Recent Developments/Updates
Table 126. Wo Hua Biotech Competitive Strengths & Weaknesses
Table 127. Zhejiang Ceva Ebvac Biotech Basic Information, Manufacturing Base and Competitors
Table 128. Zhejiang Ceva Ebvac Biotech Major Business
Table 129. Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 130. Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Zhejiang Ceva Ebvac Biotech Recent Developments/Updates
Table 132. Zhejiang Ceva Ebvac Biotech Competitive Strengths & Weaknesses
Table 133. Luoyang Huizhong Biotech Basic Information, Manufacturing Base and Competitors
Table 134. Luoyang Huizhong Biotech Major Business
Table 135. Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 136. Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Luoyang Huizhong Biotech Recent Developments/Updates
Table 138. Luoyang Huizhong Biotech Competitive Strengths & Weaknesses
Table 139. Beijing Centrebio Biology Basic Information, Manufacturing Base and Competitors
Table 140. Beijing Centrebio Biology Major Business
Table 141. Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 142. Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Beijing Centrebio Biology Recent Developments/Updates
Table 144. Beijing Centrebio Biology Competitive Strengths & Weaknesses
Table 145. Shandong Huahong Bioengineering Basic Information, Manufacturing Base and Competitors
Table 146. Shandong Huahong Bioengineering Major Business
Table 147. Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 148. Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Shandong Huahong Bioengineering Recent Developments/Updates
Table 150. Ringpu Basic Information, Manufacturing Base and Competitors
Table 151. Ringpu Major Business
Table 152. Ringpu Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 153. Ringpu Haemophilus Parasuis Bivalent Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Haemophilus Parasuis Bivalent Vaccine Upstream (Raw Materials)
Table 155. Haemophilus Parasuis Bivalent Vaccine Typical Customers
Table 156. Haemophilus Parasuis Bivalent Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Haemophilus Parasuis Bivalent Vaccine Picture
Figure 2. World Haemophilus Parasuis Bivalent Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Haemophilus Parasuis Bivalent Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Haemophilus Parasuis Bivalent Vaccine Production (2018-2029) & (K Doses)
Figure 5. World Haemophilus Parasuis Bivalent Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 6. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Haemophilus Parasuis Bivalent Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Haemophilus Parasuis Bivalent Vaccine Production (2018-2029) & (K Doses)
Figure 9. Europe Haemophilus Parasuis Bivalent Vaccine Production (2018-2029) & (K Doses)
Figure 10. China Haemophilus Parasuis Bivalent Vaccine Production (2018-2029) & (K Doses)
Figure 11. Japan Haemophilus Parasuis Bivalent Vaccine Production (2018-2029) & (K Doses)
Figure 12. Haemophilus Parasuis Bivalent Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 15. World Haemophilus Parasuis Bivalent Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 17. China Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 18. Europe Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 19. Japan Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 20. South Korea Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 21. ASEAN Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 22. India Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 23. Producer Shipments of Haemophilus Parasuis Bivalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Haemophilus Parasuis Bivalent Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Haemophilus Parasuis Bivalent Vaccine Markets in 2022
Figure 26. United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Haemophilus Parasuis Bivalent Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Market Share 2022
Figure 32. World Haemophilus Parasuis Bivalent Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Type in 2022
Figure 34. Bivalent Inactivated Vaccine
Figure 35. Trivalent Inactivated Vaccine
Figure 36. Quadrivalent Inactivated Vaccine
Figure 37. World Haemophilus Parasuis Bivalent Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 40. World Haemophilus Parasuis Bivalent Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Application in 2022
Figure 42. Piglets
Figure 43. Adults Pigs
Figure 44. World Haemophilus Parasuis Bivalent Vaccine Production Market Share by Application (2018-2029)
Figure 45. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 47. Haemophilus Parasuis Bivalent Vaccine Industry Chain
Figure 48. Haemophilus Parasuis Bivalent Vaccine Procurement Model
Figure 49. Haemophilus Parasuis Bivalent Vaccine Sales Model
Figure 50. Haemophilus Parasuis Bivalent Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Haemophilus Parasuis Bivalent Vaccine Picture
Figure 2. World Haemophilus Parasuis Bivalent Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Haemophilus Parasuis Bivalent Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Haemophilus Parasuis Bivalent Vaccine Production (2018-2029) & (K Doses)
Figure 5. World Haemophilus Parasuis Bivalent Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 6. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Haemophilus Parasuis Bivalent Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Haemophilus Parasuis Bivalent Vaccine Production (2018-2029) & (K Doses)
Figure 9. Europe Haemophilus Parasuis Bivalent Vaccine Production (2018-2029) & (K Doses)
Figure 10. China Haemophilus Parasuis Bivalent Vaccine Production (2018-2029) & (K Doses)
Figure 11. Japan Haemophilus Parasuis Bivalent Vaccine Production (2018-2029) & (K Doses)
Figure 12. Haemophilus Parasuis Bivalent Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 15. World Haemophilus Parasuis Bivalent Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 17. China Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 18. Europe Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 19. Japan Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 20. South Korea Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 21. ASEAN Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 22. India Haemophilus Parasuis Bivalent Vaccine Consumption (2018-2029) & (K Doses)
Figure 23. Producer Shipments of Haemophilus Parasuis Bivalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Haemophilus Parasuis Bivalent Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Haemophilus Parasuis Bivalent Vaccine Markets in 2022
Figure 26. United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Haemophilus Parasuis Bivalent Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Haemophilus Parasuis Bivalent Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Haemophilus Parasuis Bivalent Vaccine Production Market Share 2022
Figure 32. World Haemophilus Parasuis Bivalent Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Type in 2022
Figure 34. Bivalent Inactivated Vaccine
Figure 35. Trivalent Inactivated Vaccine
Figure 36. Quadrivalent Inactivated Vaccine
Figure 37. World Haemophilus Parasuis Bivalent Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 40. World Haemophilus Parasuis Bivalent Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Application in 2022
Figure 42. Piglets
Figure 43. Adults Pigs
Figure 44. World Haemophilus Parasuis Bivalent Vaccine Production Market Share by Application (2018-2029)
Figure 45. World Haemophilus Parasuis Bivalent Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 47. Haemophilus Parasuis Bivalent Vaccine Industry Chain
Figure 48. Haemophilus Parasuis Bivalent Vaccine Procurement Model
Figure 49. Haemophilus Parasuis Bivalent Vaccine Sales Model
Figure 50. Haemophilus Parasuis Bivalent Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
